ASN and FDA: Recognizing Ways to Increase Diversity in Clinical Trials

ASN Executive Vice President, Tod Ibrahim and ASN Past President, Jonathan Himmelfarb, MD, FASN, speak with Jonca Bull, MD and Patrick Archdeacon, MD from the FDA about ways to improve disparities in clinical trials.